Research & Resources
Research-informed care. Personalized guidance for your child’s growing eyes.
Read with context
Research helps guide myopia care, but study results do not predict an individual child's response. Age, prescription, population, treatment design and follow-up duration can all affect findings. Your doctor can help explain how the evidence applies to your child.
For families
AAPOS: Myopia and treatment in children provides an overview of childhood nearsightedness and treatment approaches.
Product and regulatory information
FDA: MiSight 1 day describes the approved indication for this daily disposable contact lens.
FDA: Myopia-control spectacle lenses explains the 2025 marketing authorization for Stellest lenses.
Selected clinical literature
ATOM2 atropine study examines concentrations of atropine for childhood myopia. It is one part of an evolving body of evidence.
MiSight three-year clinical trial reports findings on a daily disposable lens approach.
Myopic macular degeneration: global prevalence and projected trends explores the relationship between myopia and retinal risk.
Bring your questions
We welcome informed conversations. Explore common parent questions or discuss a study during your consultation.
Clinical studies, organized by treatment
Ortho-K: the two-year ROMIO trial
Daily contacts: the three-year MiSight trial
Atropine: the LAMP randomized trial
Eyeglasses: aspherical-lenslet randomized trial
These studies used different ages, populations, controls and follow-up periods. Their percentages should not be treated as a head-to-head ranking. We discuss the evidence in the context of your child's needs.
Your myopia-control care team
Myopia-control care at Village Eyes Optometry in Westwood is provided by Dr. Bahareh Golbahar, Dr. Annie Hu-Duval and Dr. Lorin Vogel. Meet our myopia-control doctors and learn how we tailor care to your child.